NEW YORK — Shares of gene therapy developer Bluebird Bio Inc. surged in their trading debut.
Its shares climbed $9.91, or 58.3 percent, to close at $26.91 Wednesday after trading as high as $27 earlier in the session.
The company's initial public offering of 5.94 million shares had been priced Tuesday at $17 per share, above its initial expectations of $14 to $16 per share.
That raised $101 million before underwriting costs and other expenses.
Bluebird is developing gene therapies for severe genetic and very rare diseases.
The underwriters of the IPO have the option to buy another 891,000 shares of the Cambridge, Mass., company over the next month.
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More From Star Tribune
More From Business
Business
How major US stock indexes fared Tuesday, 4/23/2024
Stocks rallied for a second straight day on Wall Street, softening what's been a rough April.
Business
Novartis, Danaher rise; Nucor, Cadence Design Systems fall, Tuesday, 4/23/2024
Stocks that traded heavily or had substantial price changes on Tuesday:
Business
Tesla's first-quarter net income tumbles 55% as falling global sales and price cuts reduce profits
Tesla's first-quarter net income plummeted 55% as falling global sales and price cuts sliced into the electric vehicle maker's revenue and profit margins.
Business
New federal rule would bar 'noncompete' agreements for most employees
U.S. companies would no longer be able to bar employees from taking jobs with competitors under a rule approved by a federal agency Tuesday, though the rule is sure to be challenged in court.
Business
Stock market today: Wall Street rallies for a second day, erasing some of April's losses
Stocks rallied for a second straight day on Wall Street, softening what's been a rough April. The S&P 500 added 1.2% Tuesday to pull further out of the hole created by a six-day losing streak. The Dow Jones Industrial Average climbed 0.7%, and the Nasdaq composite rose 1.6%. A weaker-than-expected report on U.S. business activity helped support the market, which remains in an awkward phase. The hope on Wall Street is for the economy to avoid a severe recession, but not to stay so hot that it keeps upward pressure on inflation. GE Aerospace soared after raising its profit forecast.
